A significant breakthrough in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many forms of tumors, leading https://peakbookmarks.com/story22029584/vhh-fragments-restore-p53-new-promising-pathway-for-malignant-therapy